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A  number  of  different  types of  apparent  receptor  sites have  been  demon- 
strated on the surface membrane of lymphocytes. These include immunoglob- 
ulin receptors for  a  variety of antigens  (1),  a  receptor for the C3  component 
of complement  (2),  and  a  possible receptor site for the Fc portion of the im- 
munoglobulin  molecule  through  which  antibody  alone  or  antigen-antibody 
complexes adhere to mouse lymphocytes (3, 4). Attempts in the present study 
to  demonstrate  such  a  receptor  for  antigen-antibody  complexes  on  human 
lymphocytes using  fluorescein-labeled antigen  or  antibody presented  a  num- 
ber  of  difficulties with  different  complexes.  One  particular  antigen-antibody 
system consistently labeled a  population  of lymphocytes while  several other 
systems  were  completely negative.  The  reason  for  this  discrepancy was  not 
apparent.  As  an  alternative  approach,  aggregated  T-globulin was  employed 
for the study of this interaction. Such preparations of T-globulin are known to 
possess many of the properties  of  antigen-antibody  complexes  and  are  con- 
siderably more stable. 
Materials and Methods 
Aggregated Human lmmunoglobulin.--Fraction  II human y-globulin (Lederle Laboratories, 
Pearl River, N. Y.) was dissolved in phosphate-buffered  saline  (PBS), 1 pH 7.2, at a concen- 
tration of 50 mg/ml. This was heat inactivated at 56°C for 30 min, and fluorescein conjugated 
as previously described (5). Conjugated and unconjugated preparations were heat aggregated 
at 63°C for  15 rain, pelleted, and homogenized in PBS, pit 8.0. Just before use, aggregates 
were centrifuged at 1000 g for 30 min and adjusted to 1-3 mg/ml. Aggregates of isolated my- 
eloma proteins were prepared in a similar manner except lower concentrations of protein were 
used to form the aggregates. Aggregates of specific size and 7S IgG were obtained by prepara- 
tive ultracentrifugation. 
Anti-lmmunoglobulin  Antiserum.--A  polyvalent anti-human  immunoglobulin  antiserum 
was raised in rabbits and conjugated with tetramethylrhodamine isothiocyanate, as described 
by Pernis et al. (6), by Dr. F. P. Siegal. The antiserum (Rho-anti-Ig) was specific for ~-, T-, 
kappa, and lambda determinants. It was centrifuged to remove aggregates immediately before 
use. 
Lymphocyte Separation.--Mononuclear  cells were  isolated from  the peripheral blood of 
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normal humans and rabbits as described by Siegal et al.  (7). The cells were then incubated on 
nylon, washed,  and  resuspended  in 2% bovine serum albumin in PBS,  pH  7.2,  0.02%  Na 
azide (BSA-PBS) at a concentration of 15-20 x  106 cells/ml. The final preparation contained 
>98% small lymphocytes which were 98-99% viable. BSA-PBS, pH 8.0, was used in experi- 
ments with aggregates of specific size. 
Fluorescence.--Immunofluorescent staining  of  lymphocyte  surface  Ig  was  performed  as 
described by Pernis et al.  (6). Two methods were used for aggregates. In the direct method, 
fluorescein-conjugated aggregated  IgG  (FI-Agg)  and  lymphocytes  (0.05  ml  of  each)  were 
incubated at 4°C for 30 min. Cells were washed in BSA-PBS, resuspended in the same medium, 
and wet mounts prepared. Slides were kept at 4°C until read. The indirect method was similar 
to the direct method except unlabeled aggregates (Agg) were used and cells were stained after 
washing with Rho-anti-Ig. Ig spots were always uniformly small and differentiable from ag- 
gregates if the Rho-anti-Ig was centrifuged, Na azide used, and slides allowed only minimaI 
time at  room temperature.  Microscopy was performed as described by Pernis et al.  (6).  A 
minimum of 200 cells per preparation were counted with reproducibility of 4- 2~0.c7 
RESULTS 
Binding  of  Aggregates  to  Normal  Human  Lymphocyles In  Vilro.--When 
peripheral  blood  lymphocytes  from  normal  human  subjects  were  incubated 
with  fluorescein-conjugated  heat-aggregated  human  IgG  (F1-Agg),  a  sub- 
population  of  approximately  22%  bound  the  aggregates.  This  binding  is 
demonstrated  i.n  Fig.  1.  The  control  experiment  using  fluorescein-conjugated 
7S  human  IgG was  completely negative.  Further,  binding  of aggregates  could 
also  be  demonstrated  using  an  indirect  method  in  which  unlabeled  heat- 
aggregated  human  IgG  (Agg)  was  incubated  with  the  cells,  which  were  then 
FIGS.  1-3.  Demonstration by direct and indirect fluorescence of IgG aggregates binding to 
human peripheral lymphocytes, and comparison with immunofluorescent staining of surface 
Ig.  (1  a)  Phase  contrast;  (1  b)  visualization of fluorescein-labeled  aggregates on one of the 
cells.  (2 a)  Phase contrast;  (2 b) visualization of one of the  lymphocytes stained with Rho- 
anti-Ig showing small,  uniform, punctate  spots.  (3 a)  Phase contrast;  (3 b)  visualization of 
one of  the  lymphocytes reacted  with  aggregates  and  then  stained  with  Rho-anti-Ig.  All 
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washed and stained with rhodamine-conjugated anti-human Ig (Rho-anti-Ig). 
The results were identical to those with the direct method and are illustrated 
in  Fig.  3.  The  aggregates  bind  to  the  lymphocyte surface  in  an  irregular, 
patchy distribution,  and the  aggregates bound to  any particular cell  varied 
in both size and number. The pattern of fluorescence was quite distinct from 
that of surface Ig  (Fig.  2)  provided that staining was carried out at 4°C in 
the presence of Na azide immediately after centrifugation of the antiserum. 
Thus,  differentiation between membrane Ig and cell-bound aggregates could 
be made even when both were present on the same cell. Aggregates of isolated 
myeloma proteins of the  ~G1  and  "rG2 subgroups gave the  same results  as 
fraction II  aggregates. This ruled out the possibility that  a  contaminant in 
fraction II was responsible for the binding to lymphocytes. 
Conditions for the Binding of Aggregates to Lymphocytes.--The  percentage of 
lymphocytes binding aggregates was not altered by temperature (4  °, 23 °, and 
37°C), pH  (6.0-8.2),  time of incubation (10 min to 4 hr), presence or absence 
of protein in the incubation medium (media tested include Hanks' balanced 
salt solution, Medium 199, 2 and 5 % BSA-PBS), presence of 0.02% Na azide, 
or presence of 0.02 M Na3 H  ethylenediaminetetraacetate. In contrast to the 
binding  of  antibody  alone  (3),  aggregate  binding  to  lymphocytes was  not 
affected by repeated washing (one to five washes). Passage over a nylon colunm 
did not significantly alter the percentage of stainable Ig bearing small lympho- 
cytes (24% pre- and 23 % postnylon) or of lymphocytes bearing the aggregate 
receptor  (23.5  %  pre-  and 22 %  postnylon). Aggregate binding was found to 
be  complement independent. The  aggregate preparations  (F1-Agg and Agg) 
contained no complement activity, and the addition of fresh normal human 
serum as a source of complement did not enhance aggregate binding. 
The maximum percentage of lymphocytes binding aggregates was obtained 
at  a  protein concentration of 0.2  mg/ml. Increasing concentrations stepwise 
up to 15  mg/ml did not enhance the number of lymphocytes binding aggre- 
gates although more aggregates were bound per cell. At still higher concentra- 
tions the preparations were less reliable because of clumping. 
Characterization  of  the  Lymphocyte Subpopulation.--The  peripheral  blood 
lymphocytes from nine normal subjects were tested in parallel for Ig staining 
and aggregate binding (Table I). For each individual and for the group as a 
whole  the percentage  of lymphocytes binding aggregates,  as determined by 
either the direct or indirect method, closely matched the percentage of lympho- 
cytes with stainable surface Ig. Normal peripheral lymphocytes from rabbits 
also  had equal percentages of Ig-staining and aggregate-binding cells.  These 
results strongly suggest that the aggregate receptor is carried by B  lympho- 
cytes. This conclusion was supported by scoring lymphocytes prepared with 
the indirect method for the presence of Ig staining, aggregate staining, or both. 
(As noted above, characteristic staining allowed for differentiation on single 
cells.) Virtually all positive cells showed both Ig patches and bound aggregates. 194  B  LYMP]:[OCYTES  AND  AGGREGATED  IGG 
TABLE I 
Surface Immunoglobulin Staining and Aggregate Binding of Normal Human 
Peripheral Lymphocytes 
Lymphocytes with  Lymphocytes binding  Lymphocytes binding 
aggregates by direct  aggregates by indirect  Subject  stainable surface Ig*  method1:  method§ 
%]]  %]i  %][ 
R.M.  13  12  11 
C.D.  14  14  15 
R.D.  15  12  17 
R.B.  23  22  24 
F.S.  24  21  21 
P.W.  24  23  22 
H.D.  25  27  27 
E.K.  27  25  29 
S.F.  40  38  40 
Mean  22.8  21.8  22.7 
* Stained with Rho-anti-Ig. 
:~ Incubated with FI-Agg. 
§ Incubated with Agg, then washed X 3 and stained with Rho-anti-Ig. 
][ Minimum of 200 cells counted for each preparation. 
0-1%  had  only Ig staining while  1-3 %  showed aggregates only. To confirm 
these results double staining experiments were performed. Lymphocytes were 
incubated  with  Rho-anti-Ig, washed  X  3,  incubated with  unlabeled  7S IgG 
to  saturate  remaining  anti-Ig sites,  washed  X  3,  and  incubated  with  either 
Fi-Agg or,  as  a  control, F1-7S IgG (Table II).  These results  showed that Ig- 
staining cells carried the aggregate receptor. That F1-Agg were not bound by 
the Rho-anti-Ig was shown by lack of fluorescence with the FI-TS IgG control. 
Additionally, these experiments provide evidence that the surface Ig and  the 
receptor for  aggregates are  separate  entities.  Even when  the  surface Ig  was 
blocked  by  anti-Ig  there  was  no  decline  in  the  percentage  of  cells  binding 
aggregates. 
In  certain  pathologic  conditions  we  have  noted  significant  numbers  of 
peripheral  lymphocytes which  bind  aggregates but  do not  stain  for Ig.  The 
question of whether these  are  B  cells  which do not have Ig on their  surface 
remains to be  answered. 
Studies of the Aggregate Receptor.--Experiments were performed to determine 
whether  any previously described  surface  component  and/or  any  substance 
known to interact with aggregated IgG was acting as the aggregate  receptor. 
As previously noted, surface Ig was unlikely to be the receptor because  block- 
ing with  anti-Ig did not diminish  binding.  Similarily,  any rheumatoid  factor 
adherent to the lymphocyte was unlikely to be the receptor as this would  also 
be  blocked  by anti-Ig. The  C3  receptor  (2)  and  the  aggregate receptor  also H.  B.  DICKLER  AND  tI.  G.  KUNKEL 
TABLE  II 
Double Labeling of B  Lymphocytes with Rhodamine-Labeled Anti-lg and 
Fluorescein-Labeled Aggregates 
195 
Percentage  lymphocytcs positive  for  Ist  Incubation  2nd Incubation  3rd Incubation 
Rho and Fl  Rho only  FI only 
Rho-anti-lg  7S IgG*  FI-Agg  23  I  2 
Rho-anti-Ig  7S IgG*  FI-TS IgG  0  24  0 
* Used to saturate remaining anti-Ig sites. 
appeared to be distinct since complement was not necessary for aggregate bind- 
ing and did not enhance the reaction. Clq is known to interact strongly with 
aggregated immunoglobulin (8). Therefore a search was made for this protein 
either adsorbed to or as part  of the lymphocyte membrane by staining with 
fluoresceinated  anti-Clq.  These  experiments  were  entirely  negative  under 
physiologic conditions. However, it was noted in the course of these experi- 
ments  that  isolated  Clq  did bind firmly to  lymphocytes. This  is  currently 
under further study. 
It seemed probable that the Fc receptor described by Basten and associates 
(3, 4) was responsible for the aggregate binding observed. Therefore, attempts 
were made to block FI-Agg binding with 7S IgG. There was no inhibition of 
the  binding  of  aggregates  despite  10-fold  greater  concentration  of  7S  IgG 
even when the cells  were not washed before the  addition of aggregates.  De- 
spite these experiments, it appears likely that the aggregates had a much higher 
binding affinity than 7S IgG because of the greater number of Fc determinants 
present and were therefore able to displace the 7S IgG and bind to the cells. 
Experiments were carried out to determine the minimum size of complexes 
which bind to lymphocytes and are visualized by the fluorescence procedures 
utilized. Aggregate fractions obtained by preparative ultracentrifugation were 
not detectable with aggregate sizes below 200S, and optimal visualization was 
obtained with fractions containing aggregates > 300S. Recent experiments in- 
dicate that smaller aggregates do bind to lymphocytes but require special pro- 
cedures for their detection. 
SUMMARY 
Specific  binding  of  aggregated  -r-globulin  to  a  subpopulation  of  lympho- 
cytes was demonstrated. This subpopulation was identified as the Ig-staining 
or B  lymphocytes. The binding was irreversible and independent of comple- 
ment, pH, temperature, protein content of the medium, and divalent cations. 
Aggregates of large size were needed for optimal visualization. Evidence was 
obtained that the site on the lymphocyte membrane responsible for binding 
aggregates was distinct from surface Ig. 196  ]3.  LYMPHOCYTES AND AGGREGATED  IGG 
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